Clinical Trial Update: Topical 2% Povidone-Iodine Gel in Verruca Vulgaris [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for topical 2% povidone-iodine gel targeting verruca vulgaris (warts).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Verruca Vulgaris
• Warts

Drugs mentioned

• topical 2% povidone-iodine gel (povidone-iodine)

Snippet

Sponsor: Veloce BioPharma LLC | Conditions: Warts | Phase 2 | Status: UNKNOWN